MIRA Pharmaceuticals Inc. (MIRA)
NASDAQ: MIRA
· Real-Time Price · USD
1.51
0.04 (2.72%)
At close: Aug 15, 2025, 3:59 PM
1.48
-1.97%
After-hours: Aug 15, 2025, 07:51 PM EDT
MIRA Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Mar 31, 2021 |
Net Income | -1.78M | -2.4M | -2.04M | -1.69M | -1.72M | -5.79M | -3.59M | -1.27M | -1.34M | -1.35M | -1.81M | -2.42M | -1.48M | -56.98K |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | 732.29K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 874.81K | 546.78K | 269.01K | 604.8K | 500.21K | 213.81 | 1.45M | 737.2K | 147.8K | 147.8K | 147.8K | 1M | n/a | n/a |
Other Working Capital | n/a | 17.37K | 22.05K | -69.17K | 58.47K | -35.48K | -39.83K | -427.79K | 116.28K | 224.48K | 345.59K | 147.89K | -571.37K | 35.63K |
Other Non-Cash Items | n/a | 225.37K | -89.31K | 145.88K | 390.65K | 4.18M | 414.24K | 295.89K | 1.65K | 1.77K | 2.31K | 2.32K | 3.86K | 4.92K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | 47.88K | -67.25K | 76.71K | 168.03K | -288.36K | -39.83K | -427.79K | 116.28K | 224.48K | 345.59K | 147.89K | -571.37K | 35.63K |
Operating Cash Flow | -1.63M | -1.81M | -1.84M | -863.93K | -1.05M | -2.14M | -1.76M | -660.81K | -1.08M | -975.44K | -1.31M | -1.27M | -2.04M | -16.42K |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | 14.47K | -14.47K | n/a | n/a | 2.24M | n/a | -219.54K | 86.48K | n/a | n/a | n/a | -50K | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | -1.35K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | 3.18M | 159.01K | -24.34K | -19.15K | -1.45M | 684.29K | 639.2K | 854K | -223.58K | -160K | -178.24K | 16.89K |
Financial Cash Flow | 3.38K | 493.4K | 3.16M | 159.01K | -24.34K | 869.35K | 7.6M | 684.29K | 725.68K | 1.14M | 676.42K | -25K | 1.36M | 16.89K |
Net Cash Flow | -1.63M | -1.31M | 1.32M | -704.91K | -1.07M | -1.27M | 5.84M | 23.47K | -349.63K | 163.56K | -638.57K | -1.3M | -686.79K | 469.00 |
Free Cash Flow | -1.63M | -1.81M | -1.84M | -863.93K | -1.05M | -2.14M | -1.76M | -660.81K | -1.08M | -975.44K | -1.31M | -1.27M | -2.04M | -16.42K |